Generic Name: cabazitaxel
Brand Name: Jevtana intravenous
Drug Reviews Drug and Medication User Reviews
Before Jevtana: metastases throughout spine and hips and a PSA of 1800. PSA reduction of about 66% after two infusions, 3 weeks apart - current PSA is 580. Platelet levels are increasing without blood transfusions. Expecting another 6 - 8 infusions until November 2011. Side effects have been difficult - a lot of hematuria and dysuria (hence the lower satisfaction score).
Receiving Jevtana infusions at 3-week intervals, PSA test results reflect 40% or greater decrease per month in PSA level. Through 6 infusions side effects have been few and minimal.